University Hospitals Birmingham NHS Foundation Trust — Birmingham

Public research footprint of University Hospitals Birmingham NHS Foundation Trust, compiled from the ClinicalTrials.gov public registry.

293

Registered studies

120

Active

Recruiting now

110

Completed

Stopped or withdrawn

Most-studied conditions

Non Small Cell Lung Cancer · Resectable Pancreatic Ductal Adenocarcinoma (PDAC) · Triple Negative Breast Cancer · Squamous Cell Carcinoma of Head and Neck

Recently updated registry entries

NCT02102165 — AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer. (Recruiting)
NCT06940141 — Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma) (Active Not Recruiting)
NCT04613596 — Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University Hospitals Birmingham NHS Foundation Trust?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.